[Temporary Announcement] Shengzhao Pharmaceuticals: Announcement on Voluntary Sales Restrictions on the Company’s Stocks Held by Shareholders

Announcement number: 2026-005 Securities code: 832586 Securities abbreviation: Shengzhao Pharmaceutical Sponsoring broker: Soochow Securities Zhejiang Shengzhao Pharmaceutical Technology Co., Ltd.

Announcement on voluntary sales restrictions on company shares held by shareholders

The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.

1. A total of 597,664 shares were subject to voluntary sales restrictions this time, accounting for 0.48% of the company’s total share capital, involving voluntary sales restrictions.

40 shareholders.

Announcement number: 2026-005

2. Details of this voluntary restriction on stock sales

Unit: Share

Whether

To control

Is it public? Is this restricted stock? Is it controlled? Is this voluntary?

The public issuance has not been completed before the issuance. After this restricted sale, the shareholders, actual shareholders, and

Shareholder’s last name Directly held before departure but may be Directors, supervisors, high-priced shares Number of shares sold Shareholder’s name

International Controller International Controller is under selling restriction on December 31, 2020. Willing to restrict selling. Voluntary selling restriction period serial number. Name or name. Accepted holding. Actual control. Relatives of senior management personnel occupying the company's shareholding without control, such as daily number of shares held. Registration status. Registered share time.

10% or more than 10% of the total share capital. Restriction clause or other, indicating the number of shares and the number of votes.

The proportion of voting rights of the above shares is consistent with the ownership relationship* amount

Shareholders* Relevant entities* Quantity actions

people

2026-1-5 to 1 Zhang Hongyao No No No No Director, Vice President 939,947 939,947 50,000 0.0398% 0 2029-1-5

2026-1-5 to 2 Huang Huifeng No No No No Director 1,212,637 1,212,637 67,664 0.0539% 0 2029-1-5

Director, Vice President, 2026-1-5 to 3 Xie Yuqi No No No No 843,700 843,700 50,000 0.0398% 0 Secretary of the Board of Directors 2029-1-5

2026-1-5 to 4 Peng Zhonghua No No No No Director 200,084 200,084 5,000 0.0040% 0 2029-1-5

2026-1-5 to 5 Wu Yingyu No No No No Vice President 538,800 538,800 31,250 0.0249% 0 2029-1-5

2026-1-5 to 6 Chen Yuanyuan No No No No Vice President 90,100 90,100 5,000 0.0040% 0 2029-1-5

Vice President, Chief Financial Officer 2026-1-5 to 7 Chai Lihua No No No No 80,000 80,000 5,000 0.0040% 0

Person in charge 2029-1-5

Announcement number: 2026-005

2026-1-5 to 8 Li Yajun No No No No None 235,650 235,650 50,000 0.0398% 0 2028-1-5

2026-1-5 to 9 Wang Qinglong No No No No None 210,100 210,100 50,000 0.0398% 0 2028-1-5

2026-1-5 to 10 Wang Zhen No No No No None 112,653 112,653 25,000 0.0199% 0 2028-1-5

2026-1-5 to 11 Liu Ximing No No No No None 174,238 174,238 20,000 0.0159% 0 2028-1-5

2026-1-5 to 12 Qi Xuefei No No No No None 104,772 104,772 22,500 0.0179% 0 2028-1-5

2026-1-5 to 13 Gao Suying No No No No None 150,000 150,000 25,000 0.0199% 0 2028-1-5

2026-1-5 to 14 Zhou Jialin No No No No None 100,398 100,398 20,000 0.0159% 0 2028-1-5

2026-1-5 to 15 Zheng Yunliang No No No No None 140,572 140,572 22,500 0.0179% 0 2028-1-5

2026-1-5 to 16 Xue Wenmou No No No No None 61,610 61,610 12,500 0.0100% 0 2028-1-5

2026-1-5 to 17 Shao Zhilin No No No No None 91,000 91,000 17,500 0.0139% 0 2028-1-5

2026-1-5 to 18 He Jiaqi No No No No None 30,000 30,000 7,500 0.0060% 0 2028-1-5

2026-1-5 to 19 Zhou Hua No No No No None 58,688 58,688 6,250 0.0050% 0 2028-1-5

2026-1-5 to 20 Wednesday Cloud No No No No None 51,477 51,477 6,250 0.0050% 0 2028-1-5

2026-1-5 to 21 Zou Jia No No No No None 47,946 47,946 6,250 0.0050% 0

2028-1-5

Announcement number: 2026-005

2026-1-5 to 22 Yu Kongtong No No No No None 25,000 25,000 6,250 0.0050% 0 2028-1-5

2026-1-5 to 23 Du Baoguo No No No No None 45,061 45,061 6,250 0.0050% 0 2028-1-5

2026-1-5 to 24 Li Haijie No No No No None 42,342 42,342 6,250 0.0050% 0 2028-1-5

2026-1-5 to 25 Xu Xing No No No No None 35,252 35,252 6,250 0.0050% 0 2028-1-5

2026-1-5 to 26 Jing Zhiyu No No No No None 25,663 25,663 5,000 0.0040% 0 2028-1-5

2026-1-5 to 27 Li Yongying No No No No None 24,280 24,280 5,000 0.0040% 0 2028-1-5

2026-1-5 to 28 Wang Jin No No No No None 36,844 36,844 3,750 0.0030% 0 2028-1-5

2026-1-5 to 29 Wang Hui No No No No None 64,559 64,559 3,750 0.0030% 0 2028-1-5

2026-1-5 to 30 Zhu Qianying No No No No None 19,365 19,365 3,750 0.0030% 0 2028-1-5

2026-1-5 to 31 Cheng Xiaohong No No No No None 15,583 15,583 2,500 0.0020% 0 2028-1-5

2026-1-5 to 32 Shao Weijun No No No No None 15,000 15,000 3,750 0.0030% 0 2028-1-5

2026-1-5 to 33 Zhu Siqi No No No No None 23,655 23,655 3,750 0.0030% 0 2028-1-5

2026-1-5 to 34 Wang Dan No No No No None 38,176 38,176 3,750 0.0030% 0 2028-1-5

2026-1-5 to 35 Li Chunhua No No No No None 41,807 41,807 5,000 0.0040% 0

2028-1-5

Announcement number: 2026-005

2026-1-5 to 36 Yi Lina No No No No None 34,569 34,569 5,000 0.0040% 0 2028-1-5

2026-1-5 to 37 Maggie Cheung No No No No None 23,034 23,034 5,000 0.0040% 0 2028-1-5

2026-1-5 to 38 Li Shuang No No No No None 10,000 10,000 2,500 0.0020% 0 2028-1-5

2026-1-5 to 39 Hong Shusheng No No No No None 10,000 10,000 2,500 0.0020% 0 2028-1-5

2026-1-5 to 40 Zhang Xiao No No No No None 50,000 50,000 12,500 0.0100% 0 2028-1-5

The listed company has applied for sales restrictions on the above stocks on January 7, 2026.

Announcement number: 2026-005

3. The basis and lifting conditions for this voluntary restriction on stock sales

Based on their confidence in the company's future development, the company's directors and senior managers have made voluntary sales restriction commitments on the non-statutorily restricted portion of the shares that have been unlocked in the first phase of the company's restricted stock incentive plan, and have handled share restrictions in accordance with the "Guidelines for the Restriction and Unlocking of Stocks in Companies Listed on the National Equities Exchange and Quotations". The sales restriction period for voluntary restricted shares is three years, from January 5, 2026 to January 5, 2029.

Based on their confidence in the company's future development, the company's core employees made voluntary sales restriction commitments for the shares they participated in in the first phase of the company's first phase of the company's restricted stock incentive plan that were unlocked, and handled share restrictions in accordance with the "Guidelines for the Restriction and Unlocking of Stocks in Companies Listed on the National Equities Exchange and Quotations". The sales restriction period for voluntary restricted shares is two years, from January 5, 2026 to January 5, 2028.

4. The company’s share capital after the voluntary restriction of stock sales

Nature of shares Number (shares) Percentage (%) Shares without sales restrictions 78,609,675 62.62%

1. Executive shares 3,350,063.00 2.67%

2. Individuals or funds 39,580,768.00 31.53% shares subject to sales restrictions

3. Other legal persons 0 0.00% share

4. Others 4,000,000.00 3.19% Total shares subject to sales restrictions 46,930,831 37.38%

Total share capital 125,540,506 100.00%

5. Other situations

The company will complete the voluntary sales restriction registration with China Securities Depository and Clearing Co., Ltd. in a timely manner.

6. Documents for reference

"Letter of Commitment on Voluntary Sales Restriction"

Board of Directors of Zhejiang Shengzhao Pharmaceutical Technology Co., Ltd.

January 7, 2026